CD274 and cancer: Recently, cancer immunotherapies, especially immune checkpoint inhibitors such as anti-PD-1 and anti-PD-L1 antibodies, have made significant advances and even won the 2018 Nobel Prize for the discovery of the mechanism of immune evasion in PD-L1/PD-1 cancers 4, 5.